title: Developments in the diagnostic procedures for von Willebrand disease.
abstract: Von Willebrand disease (VWD) is the most common inherited bleeding disorder but its diagnosis can be challenging due to the heterogeneity of the disease. VWD is mainly associated with mild mucocutaneous bleeding, although there are more severe phenotypes with bleeding from the gastrointestinal tract or even the joints. Also, surgical interventions and trauma may lead to critical bleeding events. These bleeding episodes are all related to quantitative or qualitative defects of von Willebrand factor (VWF), a multimeric glycoprotein produced by endothelial cells and megakaryocytes, which mediates platelet adhesion and aggregation and binds factor VIII (FVIII) in the circulation. This review describes the diagnostic procedures required for correct diagnosis. Accurate diagnosis and classification is required for proper treatment and counseling. Assessment of bleeding starts with the medical history. After a positive bleeding or family history, subsequent laboratory investigations will start with a panel of standard screening tests for hemostatic defects. Patients suspected of having VWD will be tested for plasma VWF antigen levels, the ability of VWF to bind platelets and FVIII activity. When VWD is confirmed, a set of subtyping tests can classify the patients as VWD types 1, 2 (A, B, M or N) or 3. The performance of some additional assays and analyses, such as VWF propeptide measurement or genetic analysis, may help in identifying the pathological mechanism behind certain defects or can guide in the choice of treatment.
authors.affiliation: Department of Thrombosis and Haemostasis, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
authors.forename: A
authors.initials: A
authors.lastname: De Jong
authors.affiliation: Department of Thrombosis and Haemostasis, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Eikenboom
mesh_terms: D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation / Q000235:genetics; D001780:Blood Coagulation Tests; D004252:DNA Mutational Analysis; D020022:Genetic Predisposition to Disease; D006470:Hemorrhage / Q000097:blood / Q000209:etiology; D006801:Humans; D025202:Molecular Diagnostic Techniques; D009154:Mutation; D010641:Phenotype; D011237:Predictive Value of Tests; D011379:Prognosis; D015203:Reproducibility of Results; D014842:von Willebrand Diseases / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000235:genetics; D014841:von Willebrand Factor / Q000032:analysis* / Q000235:genetics
chemical_list: D015415:Biomarkers; D014841:von Willebrand Factor
keywords: diagnosis; factor VIII; hemostasis; von Willebrand disease; von Willebrand factor